Koji Yashiro
Director, Pacific Business Development & Licensing MSD
Koji Yashiro is a director, business development and licensing Asia Pacific region at MSD, where he leads search and evaluation activities across Asia, with a primary focus on early-stage assets in Japan and Korea. He has more than 10 years of business development experience with several global biopharmaceutical companies including Astellas, Bayer and now MSD.
Prior to business development, Koji worked as a researcher in industry for more than 12 years at Astellas, Urogenix Inc in the US, CSIRO Animal Heath in Australia, and Higeta Shoyu in Japan. Koji received his PhD in cell and molecular physiology from the University of North Carolina at Chapel Hill, where he authored several publications including a first author paper in Nature Neuroscience.
Seminars
What is this session?
- With a high concentration of relevant companies in one place, the pharma icebreaker tables offer a guaranteed opportunity for face-to-face interactions. Whether you’re connected on the One-on-One Partnering™ portal or not, this is a formal opportunity to introduce yourself and your organization
How is this organized?
- Two weeks out from the conference, pharma will review attending biotech and biotech will review attending pharma, with both making selections to meet with companies they haven’t scheduled meetings with yet
- With these selections, we will build a schedule of company rotations through each pharma’s table, across 90 minutes
- This ensures you meet face-to-face with priority companies and can introduce yourself to new pharma contacts early in the event. Don’t miss out on this unique chance to expand your network and forge valuable connections!
- Understanding why pharma would invest. What gap are the innovative technologies filling and what is the sentiment for dealmaking right now?
- What do pharma need to see? Sharing direction into what is expected when approaching pharma as a partner
- Insights into how biotech can differentiate in crowded markets
